Takeda Pharmaceutical
TAK
#398
Rank
HK$441.11 B
Marketcap
HK$139.63
Share price
-1.55%
Change (1 day)
20.97%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): HK$26.00 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are HK$29.86 Billion. , an increase over its 2024 earnings that were of HK$17.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 HK$26.04 B49.03%
2024 HK$17.47 B-2.41%
2023 HK$17.90 B-28.14%
2022 HK$24.91 B-40.9%
2021 HK$42.16 B78.24%
2020 HK$23.65 B246.1%
2019 HK$6.83 B-48.79%
2018 HK$13.34 B-23.64%
2017 HK$17.47 B21.7%
2016 HK$14.35 B-253.01%
2015 -HK$9.39 Billion-159.65%
2014 HK$15.73 B13%
2013 HK$13.92 B2.46%
2012 HK$13.58 B-57.05%
2011 HK$31.63 B-10.49%
2010 HK$35.34 B-3.99%
2009 HK$36.81 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$253.69 B 874.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$128.05 B 391.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$92.81 B 256.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$64.56 B 147.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$71.26 B 173.64%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$180.82 B 594.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$73.00 B 180.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-HK$6.2 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$6.83 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India